given an additional 0.4 ,ug dose. In control rats, T3 levels decreased from 97+2.7 at 3 months to 75+4.7 ng/100 ml at 24 months. Likewise, Ca2`-activated myosin ATPase activity decreased from 1.04+0.05 to 0.68 + 0.05 #smol of P,/min per mg of protein, and the relative proportion of V1 of isomyosin decreased from 90 + 4.0 to 26 + 2.0%. The lowest (0.4,jg) T3 dose, which was sufficient to restore T3 levels in 24-month-old animals to 3-month control values, abolished the age decrement in myosin ATPase activity and markedly increased the proportion of V1 isomyosin present in the ventricle. These findings indicate that the senescent ventricle responds readily to small doses of T3 and strongly suggest that the age decrement in serum T3 levels is sufficient to contribute to the age-related decrease in myosin ATPase activity and V1 isomyosin content. Since these parameters correlate with ventricular contractility, the age decrement in T3 levels may also contribute to the decreased ventricular contractility and cardiac output observed in senescent rats.
INTRODUCTION
The present study explores the relationship between declining T3 levels and altered ventricular isomyosin distribution in senescent Fischer 344 rats. In animals and man, thyroid hormone increases the rate of myocardial fibre shortening and tension development in the ventricle (Buccino et al., 1967; Merillon et al., 1981) . There is a corresponding thyroid-hormone stimulation of Ca2+-activated myosin ATPase activity in the cardiac ventricle (Rovetto et al., 1972; Yazaki & Raben, 1975) . The rate of myosin-mediated ATP hydrolysis appears to limit the velocity of muscle shortening by determining the rate of actin-myosin cross-bridge formation (Alpert et al., 1979) . Thyroid hormone causes these changes in ventricular function by inducing the synthesis of an isomyosin with high ATPase activity (Morkin et al., 1983) . Intact myosin from the rat ventricle can be separated by native gel electrophoresis into three distinct components, V1, V2 and V3, in order of decreasing Ca2+-activated ATPase activity and mobility (Hoh et al., 1977) . These isomyosins contain two heavy-chain species, a and fi, that differ in amino acid sequence (Hoh et al., 1979) . V1 isomyosin contains two a-chains, V2 contains one a-and one ,3-chain and V3 contains two fl-chains. The fl heavy chain predominates in the hypothyroid state, and thyroid hormone induces the synthesis of the a heavy chain (Dillmann et al., 1983a) .
Senescent male Fischer 344 rats show a fall in circulating T3 levels that is accompanied by decreased cardiac output, decreased shortening velocity of isolated ventricular muscle fibres and decreased Ca2l-activated myosin ATPase activity (Rothbaum et al., 1973; Chesky & Rockstein, 1977; Klug & Adelman, 1979; Capasso et al., 1986) . In addition, senescent rats have a decreased proportion of V1 isomyosin in the cardiac ventricle, indicating an increased ,-and a decreased a-heavy-chain content (Capasso et al., 1986 Alzet Osmotic Minipumps were loaded with T3 dissolved in poly(ethylene glycol) 300/water (3: 1, v/v) at the concentrations required to deliver doses of 0.75, 5.0 and 15.0 ,g/24 h per 100 g in all age groups and a 0.4,ig dose in the 12-and 24-month-old groups. The pumps were implanted subcutaneously in the interscapular area by using anaesthesia induced by intramuscular injection of 5.0 mg of ketamine and 0.1 mg of acepromazine/ 100 g body weight. The anaesthetic dose was decreased to halfin 24-month-old rats because such a dose produced adequate anaesthesia and allowed rapid recovery. Control animals received sham implantations. Young and old rats recovered rapidly from the pump implantation with no mortality. During the 12-day T3 infusions, rats were housed individually, weighed daily and fed Purina Rat Chow (Ralston Purina, St. Louis, MO, U.S.A.) ad lib. At the end of the infusion, rats were killed by decapitation and blood collected for determination of total T3, free T3 and T3 binding by serum proteins. In addition, the heart and kidneys were rapidly removed, the cardiac chambers opened and both organs rinsed in ice-cold 0.9 % NaCl, blotted and weighed. The hearts were stored at -80°C until processed.
Methods
Total and free T3 levels were measured by using radioimmunoassay kits [T3 RIA Bead Kit (Abbott Laboratories, North Chicago, IL, U.S.A.) and Magic Free T3 Kit (Corning Medical and Scientific Division, Walpole, MA, U.S.A.)]. The capacity of serum proteins to bind T3 was estimated by using an 'in vitro' T3 resin uptake Kit (Travenol-Genetech, Cambridge, MA, U.S.A.). Electrophoretically homogeneous myosin was extracted from the cardiac ventricles by the method of Shiverick et al. (1975) . Myosin purity was checked by electrophoresis on SDS/polyacrylamide slab gels (Weber & Osborn, 1969) . Myosin ATPase activity was measured by incubating purified myosin in 10 mM-CaCl2/5 mmdithiothreitol/5 mM-ATP, pH 7.6, as described by Bhan & Malhotra (1976) . Isomyosins were separated by electrophoresis in 6 cm tube gels containing 4 % (w/v) total acrylamide and 3 % (w/w) NN'-methylenebisacrylamide cross-linker, the latter value being expressed as a percentage of total acrylamide (Hoh et al., 1977) . The gel buffer contained 10% (v/v) glycerol, 20 mMsodium pyrophosphate, pH 8.8, and the running buffer contained these components plus 1 mM-EDTA and 2 mM-L-cysteine. The gels were run in a Pharmacia GE-4 apparatus at 90 V for 20-24 h with recirculation of the' running buffer, which was cooled to 0-2 'C. The gels were stained with Coomassie Blue R, scanned in a densitometer, and the percentage of total myosin represented by each isomyosin was estimated by measuring the area under each peak (Dillmann, 1980; Capasso et al., 1986) . Protein concentrations were measured by a modified Lowry procedure (Hartree, 1972) .
RESULTS
Total circulating T3 levels Table 1 shows total serum T3 levels measured at the end of the 12-day T3 infusion. Eight animals were studied in each treatment category. In control animals, serum T3 levels progressively declined in the 12-and 24-monthold age groups when compared with the 3-month-old group. Although the 0.75,g T3 dose is a physiological replacement dose in young rats given constant T3 infusions (Brown & Millward, 1983) , it increased serum T3 levels in 12-and 24-month-old rats above 3-monthold-control levels. In contrast, the 0.40,ug T3 dose increased serum T3 levels in 12-and 24-month-old rats to that of 3-month-old controls. The 5 and 15 jug T3 doses caused progressive serum T3 elevations in all age groups, which were greater in older animals. Circulating free T3 levels and the capacity of serum proteins to bind T3
To determine whether free T3 levels were also decreased in untreated 12-and 24-month-old animals, free T3 levels Furthermore, the slight decrease in T3 resin uptake in the 12-and 24-month-old rats did not support decreased protein binding as the cause of the decreased total T3 levels in these animals. Therefore the senescent rats appeared to have decreased free and total T3 levels. Changes in body, heart and kidney weight resulting from the T3 infusions As shown in Table 2 , the 3-month-old controls had a 7 % gain in body weight during the 12-day treatment interval, whereas the 12-month-old controls had no change and the 24-month-old controls had a 2 % loss. In addition, the 12-and 24-month-old rats lost more weight in response to higher (5 and 15 ,g) T3 doses than the 3-month-old rats. Since hyperthyroidism causes cardiac and renal hypertrophy in rats (Beznak, 1962; Goulding et al., 1976) , heart and kidney weights are presented in Table 2 Table 3 shows Ca2"-activated ventricular myosin ATPase activity at all ages and T3 dose levels. In control animals, ATPase activity progressively declined in 12-and 24-month-old age groups when compared with 3-month-old-rat values. In the 3-month-old rats, the 0.75 and 5 ,ug T3 doses did not increase ATPase activity above control levels, whereas the 15, ug dose caused a modest increase. In the 12-and 24-month-old rats, th-e lowest (0.4,ug) T3 dose restored ATPase activity to the 3-monthold-rat control level, whereas the 0.75 and 5 jig doses caused no further increase. The highest (15 i#g) T3 dose caused a further increase in ATPase activity in the 12-month-old group, but not in the 24-month-old group.
Therefore the lowest (0.4,ug) T3 dose, which was just sufficient to restore T, levels in 24-month-old rats to 3- Table 2 . Changes in body weight (A, in g) during, and heart (B) and combined kidney (C) weights (g) at the end of, the 12-day treatment period Values presented below are means+ S.E.M. with eight animals in each treatment category. Values in parentheses refer to the percentage of initial body weight gained or lost during the treatment interval. 'NS' indicates that the weight change was not significant. Before weighing, cardiac chambers were opened and the hearts were rinsed in ice-cold 0.9 % NaCl and blotted. The renal capsule was removed before weighing the kidneys. Statistical significance: *P < 0.01, **P < 0.001 when compared with control animals of corresponding age by Student's t-test. Fig. 1 shows densitometer scans of gel preparations of ventricular isomyosins from each age group. In the 3-month-old control panel, the major peak corresponds to the fastest-migrating isomyosin, V1, which has the highest ATPase activity. The minor peaks correspond to V2 and V3 isomyosins in order of decreasing mobility and ATPase activity. In the 12-and 24-month-old control panels, the proportion of V1 isomyosin progressively decreases and proportion of V3 isomyosin increases. The shift in isomyosin profile corresponds to the lower Ca2+-activated myosin ATPase activity in 12-and 24-monthold controls as compared with 3-month-old controls. Since V1 isomyosin is the greatly predominant species in 3-month-old controls and T3 induces V1 isomyosin, the various T3 doses had little effect on isomyosin distribution and Ca2l-activated myosin ATPase activity in 3-monthold rats. On the other hand, Fig. 1 shows the marked increase in the proportion of V1 isomyosin that occurred when the lowest (0.4 tg) T3 dose was given to 12-and 24-month-old rats. Table 4 shows the percentage distribution of each isomyosin in ventricular myosin preparations at all ages and T3 dose levels. Values presented are means+S.E.M. for six animals in each treatment group. As revealed in Fig. 1 , there was a progressive decline in V1 isomyosin and an increase in V3 isomyosin when 12-and 24-month- old controls were compared with 3-month-old controls. The lowest (0.4 ,tg) T3 dose caused a marked increase in V1 isomyosin and a decrease in V3 isomyosin in the 12-and 24-month-old age groups. Whereas T3 doses of 0.75,ug and greater totally eliminated V2 and V3 isomyosins in 3-month-old animals, residual V2 and V3 isomyosins remained in 12-and 24-month-old animals at all T3 dose levels.
DISCUSSION
A small T3 dose that was just sufficient to raise circulating T3 levels in 24-month-old animals to that of 3-month-old animals also abolished the age decrement in ventricular myosin ATPase activity and markedly increased the percentage of V1 isomyosin in old animals. These findings strongly suggest that the age decrement in serum T3 levels in male Fischer 344 rats is sufficient to contribute to the age-related decrease in Ca2+-activated myosin ATPase activity and V1 isomyosin content in these animals. Furthermore, these studies show that the senescent ventricular myocardium responds readily to small T3 doses. Since Ca2+-activated myosin ATPase activity and V1 isomyosin content correlate with muscle contractility (Alpert et al., 1979; Scheuer & Bhan, 1979; Capasso et al., 1986) , the age decrement in T3 levels may also contribute to the decreased rate of ventricular muscle fibre shortening and decreased cardiac output reported in senescent Fischer 344 rats (Rothbaum et al., 1973; Capasso et al., 1986) . Additional studies are needed to determine whether small doses of T3 can improve the contractile performance of the senescent cardiac ventricle.
Although myosin ATPase activity and the percentage of V1 isomyosin in the ventricles of 12-and 24-month-old animals increased readily in response to the lowest (0.4,cg) T3 dose, residual V2 and V3 isomyosin remained in 1-and 24-month-old animals, even at much higher (5 and 15,g) T3 doses. Since the half-life of myosin heavy chains is 5.5 days in young rats (Martin et al., 1977) and may be greater in old rats, a large fraction of the V2 and V3 isomyosins remaining in old rats after the 12-day T3 infusion may have been synthesized before T3 treatment. Therefore the small (0.4,tg) T3 dose may have restored V1 isomyosin levels in the old rats to, or near, 3-monthold control levels without eliminating residual V2 and V3 isomyosins. The decreasing percentage of V2 and V3 isomyosins in old rats given large T3 doses may be related to increased degradation of V2 and V3 isomyosins as well as increased synthesis of V1 isomyosin. Since the present study estimated the percentage distribution of ventricular isomyosins rather than absolute concentrations, it is uncertain whether the 0.4,g T3 dose restored the absolute V1 isomyosin content in 12-and 24-month-old-rat ventricles to that of 3-month-old-rat ventricles. Nevertheless, the 0.4,g T3 dose appears to have at least caused a substantial increase in the V1 isomyosin content in 12-and 24-month-old-rat ventricles, because it eliminated the age decrement in myosin ATPase activity and markedly changed the isomyosin profile.
Since malnutrition and illness may decrease T3 levels (Wartofsky & Burman, 1982) , it may be questioned whether the decreased T3 levels and accompanying changes observed in the present study resulted from disease, altered nutritional status or old age. All rats used in the present study were obtained from the National Institute on Aging, where efforts are made to maintain a healthy colony of animals for aging studies. All rats were entered into experiments within 2 weeks of purchase, and animals with apparent illness were excluded. Young and old animals appeared to recover rapidly from the minor surgery and the anaesthesia required for osmoticminipump implantation which resulted in no mortality. All 24-month-old controls had T3 levels below the mean of the 3-month-old controls, indicating that low T3 values were uniform in the old animals and not confined to a subgroup. Furthermore, other investigators have reported similar findings in senescent Fischer 344 rats, such as decreased ventricular myosin ATPase activity (Chesky & Rockstein, 1977; Capasso et al., 1986) and decreased percentage of V1 isomyosin in the ventricle (Capasso et al., 1986) . Therefore it is likely that the decreased T3 levels, diminished ventricular myosin ATPase activity and altered isomyosin profile observed in the present study are general features of senescent male Fischer 344 rats and not restricted to the sample used in these experiments.
The age-related decrement in serum T3 levels observed in the present study is one of several instances in which a decrease in T3 levels short of those producing frank hypothyroidism appears to have regulatory significance. Decreased T3 levels in uraemic rats were associated with decreased hepatic ac-glycerophosphate dehydrogenase and malate dehydrogenase activities, which were restored to normal by physiological doses of T3 (Lim et al., 1980) . Likewise, feeding a restricted low-carbohydrate diet to rats decreased T3 levels and V1 isomyosin content in the cardiac ventricle (Dillmann et al., 1983b) . Again, a physiological dose of T3 restored the isomyosin profile to normal.
